Efficacy and Mechanism of Action of Low Dose Emetine against Human Cytomegalovirus

Natural Plant Alkaloid (Emetine) Inhibits HIV-1 Replication by Interfering with Reverse Transcriptase Activity

(2015) Ana Valadão et al.   MOLECULES

Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease

(2015) David W. Kimberlin et al.   NEW ENGLAND JOURNAL OF MEDICINE

New Cell-Signaling Pathways for Controlling Cytomegalovirus Replication

(2014) S. Roy et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Activation of Nucleotide Oligomerization Domain 2 (NOD2) by Human Cytomegalovirus Initiates Innate Immune Responses and Restricts Virus Replication

(2014) Arun Kapoor et al.   PLoS One

In VitroCombination of Anti-Cytomegalovirus Compounds Acting through Different Targets: Role of the Slope Parameter and Insights into Mechanisms of Action

(2013) Hongyi Cai et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Generation and characterization of a GCV resistant HCMV UL97-mutation and a drug sensitive UL54-mutation

(2013) Lena Fischer et al.   ANTIVIRAL RESEARCH

The “Silent” Global Burden of Congenital Cytomegalovirus

(2013) Sheetal Manicklal et al.   CLINICAL MICROBIOLOGY REVIEWS

TP53 suppression promotes erythropoiesis in del(5q) MDS, suggesting a targeted therapeutic strategy in lenalidomide-resistant patients

(2013) G. Caceres et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A quantitative basis for antiretroviral therapy for HIV-1 infection

(2012) Benjamin L Jilek et al.   NATURE MEDICINE

Ribosomal protein S14 unties the MDM2–p53 loop upon ribosomal stress

(2012) X Zhou et al.   ONCOGENE

First Report of Successful Treatment of Multidrug-Resistant Cytomegalovirus Disease with the Novel Anti-CMV Compound AIC246

(2011) D. R. Kaul et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Imaging protein synthesis in cells and tissues with an alkyne analog of puromycin

(2011) J. Liu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Recombinant luciferase-expressing human cytomegalovirus (CMV) for evaluation of CMV inhibitors

(2011) Ran He et al.   Virology Journal

In Vitro and In Vivo Activities of the Novel Anticytomegalovirus Compound AIC246

(2010) P. Lischka et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antiviral Drug Resistance of Human Cytomegalovirus

(2010) N. S. Lurain et al.   CLINICAL MICROBIOLOGY REVIEWS

The search for new therapies for human cytomegalovirus infections

(2010) Mark N. Prichard et al.   VIRUS RESEARCH

Antiviral treatment of cytomegalovirus infection and resistant strains

(2009) Andreas Schreiber et al.   EXPERT OPINION ON PHARMACOTHERAPY

A Proviral Role for CpG in Cytomegalovirus Infection

(2009) A.-C. Iversen et al.   JOURNAL OF IMMUNOLOGY

Human Cytomegalovirus IE1-72 Protein Interacts with p53 and Inhibits p53-Dependent Transactivation by a Mechanism Different from That of IE2-86 Protein

(2009) E.-S. Hwang et al.   JOURNAL OF VIROLOGY

Mortality Associated with Resistant Cytomegalovirus among Patients with Cytomegalovirus Retinitis and AIDS

(2009) Douglas A. Jabs et al.   OPHTHALMOLOGY

Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study

(2008) D. J. Winston et al.   BLOOD

Alkaloids Induce Programmed Cell Death in Bloodstream Forms of Trypanosomes (Trypanosoma b. brucei)

(2008) Vera Rosenkranz et al.   MOLECULES

Identification of RPS14 as a 5q- syndrome gene by RNA interference screen

(2008) Benjamin L. Ebert et al.   NATURE

Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs

(2008) Lin Shen et al.   NATURE MEDICINE

Dose translation from animal to human studies revisited

(2007) Shannon Reagan-Shaw et al.   FASEB JOURNAL